Cite
APA Citation
Guidi, L., Pugliese, D., Tonucci, T. P., Bertani, L., Costa, F., Privitera, G., Tolusso, B., Di Mario, C., Albano, E., Tapete, G., Gremese, E., Papa, A., Gasbarrini, A., Rapaccini, G. L., & Armuzzi, A. (2019). early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease. United European Gastroenterology journal, 7(9), 1189–1197. http://access.bl.uk/ark:/81055/vdc_100124354211.0x00000d